SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-240440
Filing Date
2019-09-09
Accepted
2019-09-09 06:46:10
Documents
14
Period of Report
2019-09-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d800506d8k.htm   iXBRL 8-K 32096
2 EX-99.1 d800506dex991.htm EX-99.1 27618
6 GRAPHIC g800506g0909073947301.jpg GRAPHIC 3108
  Complete submission text file 0001193125-19-240440.txt   197143

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA acad-20190909.xsd EX-101.SCH 3081
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE acad-20190909_lab.xml EX-101.LAB 18138
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acad-20190909_pre.xml EX-101.PRE 11415
7 EXTRACTED XBRL INSTANCE DOCUMENT d800506d8k_htm.xml XML 3417
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50768 | Film No.: 191080803
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1